FRM
CRMD icon

Fox Run Management’s CorMedix CRMD Stock Holding History

Fox Run Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+30,785
New +$243K 0.04% 755
2025
Q1 		– Sell
-14,114
Closed -$114K – 961
2024
Q4 		$114K Buy
+14,114
New +$141K 0.02% 797

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fox Run Management's CRMD Position: Q2 2026 in Review

Fox Run Management opened a new position in CorMedix (CRMD) in Q2 2026: 30,785 shares worth $242K. The stake represents 0.04% of the portfolio and ranks #755 among its holdings. This is a return to the name: Fox Run Management previously reported a position in CRMD as recently as Q4 2024.

Fox Run Management first reported a position in CRMD in Q4 2024 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Fox Run Management held 30,785 shares of CorMedix worth $242K as of Q2 2026.
  • CorMedix was a new Fox Run Management position in Q2 2026.
  • CorMedix made up 0.04% of Fox Run Management's portfolio in Q2 2026, its #755 holding.
  • Fox Run Management first reported a position in CorMedix in Q4 2024 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.